FDA panel to discuss Benlysta for lupus

FDA's Arthritis Advisory Committee will meet on Nov. 16 to discuss a BLA from Human Genome Sciences Inc. (NASDAQ:HGSI) for Benlysta belimumab to treat systemic lupus erythematosus (SLE). The human ant...